GordonMD Global Investments
Beverly Hills, California, United StatesFounded 2021
GordonMD Global Investments is a Beverly Hills-based alternative investment firm founded in 2021 by Craig Gordon, MD, focused exclusively on global biopharmaceutical and life sciences companies. The firm manages both private and public funds, targeting differentiated investment opportunities across private and publicly traded growth-stage companies.
56% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Average disclosed round size is $89.1M (across 8 rounds with reported amounts).
Portfolio
9
Fund Size
$322.3M
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Cyllene | Series C | — | Jul 2026 |
 Stipple Bio | Series A | $100M | Apr 2026 |
 Star Therapeutics | Series D | $125M | Jan 2025 |
| SStar Tx | Series D | $125M | Jan 2025 |
 Radionetics Oncology | Series A | $52.5M | Jan 2024 |
| KKyverna Therapeutics | Series B | $60M | Aug 2023 |
| SSalioGen Therapeutics | Series B | $115M | Jan 2022 |
 SalioGen | Series B | $115M | Jan 2022 |
 Rapalogix | Series A | $20M | — |
Top Co-Investors
Frazier Life Sciences3 shared
RA Capital Management2 shared
Sanofi Ventures2 shared
Cormorant Asset Management2 shared
Viking Global Investors2 shared
D1 Capital Partners2 shared
T. Rowe Price2 shared
RD Fund2 shared
Cystic Fibrosis Foundation2 shared
SymBiosis2 shared
EPIQ Capital Group2 shared
GV1 shared
Lorax Capital Partners1 shared
Nextech Invest Ltd.1 shared
Emerson Collective1 shared
New Leaf Venture Partners1 shared
Blue Owl Capital1 shared
Catalio Capital Management1 shared
Agent Capital1 shared
Last updated: 8 September 2026